UNSPSC 51287002: Acetosulfone or sulfadiasulfone

This classification denotes a sulfone anti-infective agent with the molecular formula C14H14N3O5S2.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FQ3M2Y4BU3, chemically known as 4, 4-diaminodiphenylsulfone-2-n-acetylsulfonamide, but more generally known as acetosulfone, which bears US NIH Compound Identifier 31400. European Medicines Agency schedules Sulfadiasulfone sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04621MIG.

The term SULFADIASULFONE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 16, No. 3 1962, List 4). SMILES: S(=O)(=O)(C1C(S(=O)(=O)NC(=O)C)CC(N)CC1)C1CCC(N)CC1.

UNSPSC 51287002 Acetosulfone or sulfadiasulfone is a Commodity code that shows little relevant recent activity under that specific chemical name. The recent opportunities tagged to this code — naloxone procurement, therapeutic pharmacy initiatives, medical and first aid supplies for fire rescue, and multi-source generic pharmaceuticals through cooperative purchasing — do not align with acetosulfone's pharmaceutical scope. State and local health agencies and purchasing cooperatives are actively procuring pharmaceuticals and medical supplies, but the opportunities on record reflect naloxone (an opioid antagonist), over-the-counter products, and generic multi-source drugs distributed through established wholesaler networks, not sulfonamide antibiotics or related compounds. The issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS), municipal fire departments (City of Tampa), and multistate cooperative purchasing alliances (Minnesota MMCAP serving state and local facilities across multiple states including Oregon).

Recent opportunities under this code span Florida, Texas, and the Upper Midwest through MMCAP's multistate footprint. Seminole County, Florida issued IFB 60459723LAS in June 2026 for naloxone and drug deactivation systems with a due date of July 26, 2026. The Texas HHS Commission posted RFI HHS0017013 in April 2026 to explore direct-to-manufacturer prescription programs. The City of Tampa issued ITB 26P00145 in March 2026 for medical and first aid supplies (estimated at $700,000) reserved for certified Small Local Business Enterprises with a 5 percent bid discount, due March 13, 2026. MMCAP posted RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products, with proposals due March 26, 2026 and awards effective July 1, 2026. The mismatch between the code's chemical specificity and the breadth of pharmaceutical and medical-supply procurements on record suggests this code may be improperly tagged or sees minimal activity in its primary therapeutic category.